Semnur Pharmaceuticals SMNR
OTC SMNR
$0.37 -0.01 (-2.63%)
At close: Oct 23, 2026 · 4:00 PM EDT

Semnur Pharmaceuticals (SMNR) Total Current Liabilities (2022 - 2026)

Updated

Semnur Pharmaceuticals' Total Current Liabilities came in at $10.67 million for Q2 2026, up 29.1% from $8.27 million a year earlier and up 2.8% from the prior quarter.

Analysis

Semnur Pharmaceuticals (SMNR) Total Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, Semnur Pharmaceuticals' Total Current Liabilities was $10.17 million.

  • Total Current Liabilities carries a three-year compound annual growth rate of 98.9% (FY2022 to FY2025).
  • Going back by year, Total Current Liabilities was $35,000 in FY2024 (-99.4%), $5.6 million in FY2023 (+333.9%) and $1.29 million in FY2022.
  • The Q2 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q1 2022.
  • Year-over-year, Total Current Liabilities increased in six of the last seven quarters, with growth averaging 15.1%.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q1 2023 (growth of 595.6%), and the weakest in Q4 2024 (a decline of 99.4%).
  • Business Quant data shows SMNR's Total Current Liabilities at $10.38 million (Q1 2026), $10.17 million (Q4 2025) and $10.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 55.46 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 41.64 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 11.02 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 32.65 Bn
10 Semnur Pharmaceuticals 85.18 Mn 84.92 Mn - 10.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.67 Mn
Mar 31, 2026 10.38 Mn
Dec 31, 2025 10.17 Mn
Sep 30, 2025 10.03 Mn
Jun 30, 2025 8.27 Mn
Mar 31, 2025 7.85 Mn
Dec 31, 2024 35,000.00
Sep 30, 2024 6.59 Mn
Jun 30, 2024 6.32 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 5.60 Mn
Sep 30, 2023 5.08 Mn
Jun 30, 2023 3.75 Mn
Mar 31, 2023 2.98 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 90,803.00
Jun 30, 2022 162,303.00
Mar 31, 2022 428,225.00
API Access

Semnur Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SMNR&period=max&api_key=YOUR_API_KEY